Omeprazole Genoptim

Omeprazole, the active ingredient in Omeprazole Genoptim, is a proton pump inhibitor presented as a tablet for oral use. It treats conditions caused by excess gastric acid, such as gastro‑oesophageal reflux disease and peptic ulcer disease, in adult patients. GNH USA supplies Omeprazole Genoptim as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole is a proton pump inhibitor used to reduce gastric acid production in several gastrointestinal disorders.

Gastro‑oesophageal reflux disease (GERD): reduces acid reflux symptoms and promotes healing of the esophageal lining. Peptic ulcer disease: facilitates ulcer healing by suppressing gastric acid secretion. Zollinger‑Ellison syndrome: controls hyper‑secretion of gastric acid associated with gastrin‑producing tumors. Helicobacter pylori eradication (in combination therapy): enhances the effectiveness of antibiotic regimens by creating a less acidic gastric environment.

Common Side Effects: - Headache: mild to moderate intensity. - Abdominal pain: occasional discomfort in the upper abdomen. - Diarrhoea: loose stools occurring intermittently. - Nausea: feeling of queasiness without vomiting. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): swelling, rash, difficulty breathing. - Clostridium difficile‑associated diarrhoea: severe colitis with watery stools. - Hypomagnesemia: low serum magnesium leading to muscle cramps or arrhythmia. - Bone fracture risk: decreased calcium absorption with long‑term use. - Stevens‑Johnson syndrome/toxic epidermal necrolysis: severe skin reactions.

Before initiating therapy, consider the following precautions: - Assess renal function: adjust use in severe renal impairment. - Monitor for infection: be vigilant for signs of C. difficile colitis. - Avoid prolonged use without supervision: increased risk of fractures and nutrient deficiencies. - Use caution in pregnancy: limited safety data, weigh benefits against risks. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Omeprazole may interact with several medicines, requiring attention to dosing and monitoring.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk. - Atazanavir: decreased absorption, leading to sub‑therapeutic levels. - High‑dose methotrexate: increased toxicity due to reduced clearance.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, requiring more frequent monitoring. - Diazepam: elevated plasma concentrations, may enhance sedation. - Digoxin: potential rise in serum levels, necessitating cardiac monitoring.